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Purpose: The characteristics of progression of atherosclerotic o clusive disease (AOD) of 
the lower extremities after revascularization are unknown. Duplex scanning or angiog- 
raphy were used to determine progression in 150 patients after they underwent 
revascularization for AOD. 
Methods: Follow-up studies were compared with presurgical arteriograms. Superficial 
femoral (SFA) and popliteal arteries were graded as less than 50% stenosis, 50% to 99% 
stenosis, or occluded. Tibial arteries were graded with regard to whether they were 
continuously patent from the popliteal trifurcation to the ankle. Progression was defined 
as an increase in one stenosis category. 
Results: At a mean follow-up of 4.8 years, 18% of native arteries, 39% of extremities, and 
52% of patients demonstrated progression of AOD. Overall, 21% of arteries in patients 
undergoing infraingulnal bypass and 14% of arteries in patients undergoing suprainguinal 
bypass demonstrated progression (p = 0.004). Progression was more frequently detected 
in examinations performed more than 4 years after baseline arteriography (66%) than in 
examinations performed 6 months to 2 years (45%, p = 0.032) or 2 to 4 years (44%, 
p = 0.029) after baseline arteriography. Thirty percent of SFAs demonstrated progres- 
sion, and 32% with 50% stenosis or greater at baseline became occluded. There was no 
difference in SFA, popliteal, or tibial artery progression in revascularized versus 
nonrevascularized extremities after suprainguinal bypass. There was no difference in tibial 
artery progression i operated and nonoperated limbs after femoropopliteal artery bypass. 
Conclusions: AOD progression occurs frequently in patients requiring revascularization 
and is more prevalent in patients requiring femoropopliteal than in patients requiring 
suprainguinal bypass. AOD progression in patients undergoing vascular surgery is 
associated with the pattern of disease producing lower extremity ischemia nd does not 
appear to be worsened by arterial reconstruction. (J VAsc SURG 1995;22:450-6.) 
Each year many thousands of major lower ex- 
tremity revascularizations are performed to treat 
symptoms of  lower extremity atherosclerosis. 1-3 De- 
spite the major morbidity potentially associated with 
progression of lower extremity atherosclerotic o clu- 
sive disease, anatomic progression of  atherosclerosis 
has only been studied directly in coronary, cervical, 
carotid, and renal arteries .4-7 Studies of lower extrem- 
ity atherosclerosis progression have almost exclu- 
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sively been indirect, on the basis of  either symptoms, 
segmental Doppler pressures, or the need for 
amputation, sl° Surprisingly even postoperative pa- 
tients who potentially have the most to lose from 
progression of lower extremity atherosclerosis have 
not been systematically studied for progression of 
arterial disease. Postoperative studies in patients 
undergoing revascularization have instead focused 
almost exclusively on graft patency, ha2 Information 
regarding progression is needed to properly design 
studies of medical and surgical therapies of lower 
extremity atherosclerosis, as well as to determine 
whether evascularization adversely influences pro- 
gression of arterial disease. 
Direct studies of progression of lower extremity 
atherosclerosis have been limited because of the need 
for angiography to accurately evaluate lower extrem- 
ity arteries. However, duplex scanning of lower 
extremity arteries has now achieved sufficient accu- 
racy that it can be used to evaluate the lower extremity 
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arterial circulation from the aortic bifurcation to the 
ankle. 13 In this study, we used duplex scanning or 
follow-up artcriography to detect progression of 
lower extremity atherosclerosis in operated and 
nonoperated limbs of patients at varying intervals 
after arterial reconstruction for chronic lower extrem- 
ity ischemia. 
The study was designed to address the following 
clinical questions. First, what is the prevalence of 
progression of atherosclerosis in arteries distal to 
lower extremity revascularization? Second, is pro- 
gression more frequent in extremities undergoing 
aortoiliac revascularization than in those undergoing 
femoropopliteal revascularization? Third, is progres- 
sion more frequent in operated or unoperated 
extremities ? 
METHODS 
Patient selection and grouping of lower ex- 
tremities. Consecutive patents in the vascular sur- 
gery outpatient clinic were recruited from those who 
had an inflow procedure (aortofemoral, crossfemo- 
ral, or axillofemoral bypass or an iliac artery balloon 
angioplasty) or a femoral popliteal bypass for occlu- 
sive atherosclerotic disease. Patients were eligible for 
study if at least 6 months had passed since revascu- 
larization was performed. Each patient was charac- 
terized with respect o atherosclerotic risk factors, 
including hypertension, diabetes mellitus, hypercho- 
lesterolemia, chronic renal insufficiency (serum cre- 
atinine greater than 1.5 mg/dl on two separate 
determinations), and whether they smoked at any 
time during follow-up. The study was approved by 
the Institutional Review Boards of both the Oregon 
Health Sciences University and the Portland, Oregon 
Department of Veteran's Affairs Hospital. All pa- 
tients signed informed consent. 
Each leg was classified into one of four groups. 
Nonoperated lower extremities were classified into 
group 1, those contralateral to an extremity with a 
femoropopliteal bypass, or group 2, those acting as 
the donor artery in a femorofemoral bypass or those 
contralateral to an iliac artery balloon angioplasty. 
Extremities with an arterial reconstruction were 
classified as having had an inflow procedure (aorto- 
bifemoral or axillobifemoral bypass or iliac artery 
balloon angioplasty) (group 3) or a femoropopliteal 
bypass (group 4). 
Baseline lower extremity arteriography. The 
status of the arteries on the patient's initial preopera- 
tive arteriogram was used as the basis for evaluating 
subsequent progression of arterial occlusive disease. 
In groups 1, 2, and 3, superficial femoral and 
popliteal arteries were evaluated. Superficial femoral 
and popliteal arteries were not evaluated infollow-up 
in extremities initially undergoing a femoropopliteal 
bypass (group 4). This is because in group 4 
extremities, the superficial femoral artery was gener- 
ally occluded at baseline, and progression of disease 
in the popliteal artery caused by paraanastomotic 
fibrointimal hyperplasia rather than atherosclerosis 
cannot be distinguished by duplex scanning. In all 
groups, anterior and posterior tibial arteries were 
classified with regard to whether they were continu- 
ously patent from the level of the popliteal trifurca- 
tion to the ankle. Tibial arteries that were initially 
segmentally occluded were classified as occluded. The 
peroneal artery was not studied because previous 
studies have shown that it is less accurately assessed 
with duplex scanning than the anterior and posterior 
tibial arteries. 13 
Follow-up studies. Follow-up examination was 
performed with angiography (20% of examinations) 
or duplex scanning (80% of examinations). Duplex 
scanning represented the only procedure obtained 
solely for the purposes of the study. Arteriography 
was obtained if clinically indicated. Both accuracy 
and technique of lower extremity arterial duplex 
scanning in our laboratory have been previously 
reported. 13
Some patients had more than one follow-up 
examination. This occurred when patients had inter- 
vening arteriograms before the final examination 
obtained for the study or when patients had second- 
ary operative procedures. 
Superficial femoral and popliteal arteries were 
graded on follow-up angiography or duplex exami- 
nation as either 0% to 49%, 50% to 99%, or 
occluded. Each anterior and posterior tibial artery 
continuously patent on the initial preoperative arte- 
riogram was graded on follow-up examination with 
regard to whether continuous patency was main- 
tained from the popliteal trifurcation to the ankle. 
Disease progression was defined in the femoral and 
popliteal arteries as an increase in one category of 
stenosis. Progression was defined for the anterior and 
posterior tibial arteries as a vessel continuously patent 
from the popliteal trifurcation to the ankle subse- 
quently becoming either segmentally or totally oc- 
cluded. 
Data analysis. Follow-up examinations were 
grouped with regard to whether they occurred 6 
months to 2 years, 2 to 4 years, or more than 4 years 
after the baseline arteriogram was obtained. Preva- 
lence of arterial occlusive disease progression i each 
extremity group was determined by analysis for any 
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progression detected by duplex scanning or angiog- 
raphy compared with baseline arteriography. Preva- 
lence of disease progression i  operated and unop- 
erated extremities in patients after undergoing a
suprainguinal procedure (groups 2 and 3) was 
compared with operated and unoperated extremities 
in patients undergoing an infrainguinal procedure 
(groups 1 and 4). The influence of suprainguinal 
revascularization progression of distal occlusive 
disease was determined by comparing disease pro- 
gression in the superficial femoral, popliteal, and 
tibial arteries in unoperated limbs (group 2) and 
operated limbs (group 3). Tibial artery progression 
in unoperated limbs (group 1) was compared with 
operated limbs (group 4) to determine the influence 
of infrainguinal reconstruction on distal disease 
progression. 
Statistical analysis. Statistical methods included 
t test and chi-squared analysis. Multivariate stepwise 
logistic regression analysis was used to control for the 
potential confounding effect of risk factors on 
atherosclerotic progression. In all analyses, groups 
were considered significantly different ifp < 0.05. 
RESULTS 
Patients. One hundred fifty patients were entered 
into the study; 104 were men, and 46 were women. 
The mean age was 66.5 years (range 34 years to 93 
years). Sixty-four percent had hypertension, 25% had 
diabetes, 33% had hypercholesterolemia, 14% had 
chronic lddney failure, and 89% continued to smoke 
during the follow-up period. 
Two hundred six follow-up examinations were 
performed in the 150 patients. One hundred three 
patients underwent a single examination, 38 patients 
underwent two examinations, and 9 patients under- 
went three examinations. Ninety-four examined ex- 
tremities were not revascularized. Fifty-one were 
contralateral extremities in patients with a femo- 
ropopliteal bypass graft (group 1) and 43 were either 
the donor extremities for femoral-femoral bypass 
grafts or were contralateral to iliac artery angioplas- 
ties (group 2). Ninety-three xamined extremities 
had suprainguinal procedures (group 3), and 77 had 
femoropopliteal bypass grafts (group 4). A total of 
264 extremities were therefore studied. The remain- 
ing 36 extremities were excluded because of inad- 
equate baseline angiography or prior amputation. 
Initial arteriogram. In the 264 eligible extremi- 
ties, 83% (765/926) of the arteries were patent on the 
initial arteriogram and could be used as a basis for 
comparison with the follow-up arteriogram or du- 
plex scan (Table I). There were 159 patent superficial 
femoral arteries, 171 patent popliteal arteries, 205 
patent anterior tibial arteries, and 230 patent poste- 
rior tibial arteries. 
Progression of arterial occlusive disease. Sev- 
enty-nine (53%) of the 150 patients had progression 
of arterial occlusive disease in at least one artery 
(mean follow-up 4.8 years, range 0.5 years to 20 
years). Twenty-one percent of the arteries examined 
(67 of 324) and 66% of patients examined at greater 
than 4 years after baseline arteriography demon- 
strated detectable progression of disease. Fifteen 
percent of the arteries examined (47 of 313) and 44% 
of patients examined 2 to 4 years after baseline 
artcriography demonstrated isease progression. 
Seventeen percent of the arteries examined (47 of 
351) and 45% of the patients examined 6 months to 
2 years after baseline arteriography demonstrated 
disease progression. The likelihood of a patient 
demonstrating detectable disease progression was 
significantly greater at more than 4 years after 
baseline arteriography than at 2 to 4 years 
(p = 0.029) or at 6 months to 2 years (p = 0.032). 
Overall, 18% of the 755 arteries patent on the 
baseline arteriogram had detectable disease progres- 
sion on follow-up examination. Fifty-two of 159 
(30%) patent superficial femoral arteries on baseline 
arteriography ad progression of occlusive disease on 
follow-up study. Thirty-two percent of superficial 
femoral arteries with a 50% or greater stenosis 
(n = 31) at baseline arteriography progressed to 
occlusion. Two superficial femoral arteries were 
noted to have regression ofatherosclerosis from 50% 
to 99% to less than 50%. Regression was docu- 
mented by arteriography in one patient and by duplex 
scanning in the other. Fourteen percent of patent 
anterior and posterior tibial arteries at baseline 
arteriography (n = 435) were found on follow-up 
examination to have either total or segmental occlu- 
sion. No recanalization f previously occluded arter- 
ies was observed. There was no significantly increased 
prevalence of progression detected on follow-up 
when patients were stratified to age, sex, and athero- 
sclerotic risk factors;p > 0.05 for all variables tested. 
Arteries in patients undergoing infrainguinal 
bypass (groups 1 and 4) demonstrated significantly 
more progression than those in patients undergoing 
suprainguinal bypass (groups 2 and 3); 21% versus 
14%, respectively (p = 0.004) (Table II). Multivari- 
ate stepwise logistic analysis also revealed a history of 
smoldng (p = 0.04, odds ratio 3.8) and length of 
follow-up (p = 0.02) to be significant in contribut- 
ing to progression in patients undergoing infrain- 
guinal bypass. Adjusting for these factors did not 
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Table I. Patent arteries (n = 765) on initial arteriography in 150 patients undergoing operation 
for chronic lower extremity ischemia* 
Artery 
Superficial femoral Popliteal Anterior tibial Posterior tibial 
(no.) (no.) (no.) (no.) 
Group 1 36 44 35 41 
Group 2 37 37 31 33 
Group 3 86 90 79 92 
Group 4 NA NA 60 64 
Total 159 171 205 230 
NA, Not applicable. 
*Group 1, Nonoperated contralateral extremity in a patient with a femoropopliteal bypass; group 2, donor extremity in a patient with 
a femorofemoral bypass and extremities contralateral to an iliac artery balloon angioplasty; group 3, extremities revascularized with a 
suprainguinal bypass or angioplasty; group 4, extremities revascularized with a femoral popliteal bypass. 
Table II. Number (percent) of  arteries with detectable progression of  arterial occlusive disease in 
examinations performed at 6 months to 2 years, 2 to 4 years, and greater than 4 years after lower 
extremity infrainguinal or suprainguinal revascularization 
Observation i terval 
Groups 6 months-2 years 2-4 years > 4 years 
Infrainguinal 
Group 1 
Superficial femoral 6/23 (26) 5/12 (41) 5/9 (56) 
Popliteal 5/26 (19) 3/14 (21) 3/11 (27) 
Tibial (Ant. and Post.) 9/40 (23) 4/24 (13) 2/23 (9) 
Group 4 
Tibial (Ant. and Post.) 9/78 (12) 8/64 (13) 23/62 (37) 
Totals 29/167 (17) 20/114 (18) 33/105 (31) 
Suprainguinal 
Group II 
Superficial femoral 4/15 (27) 2/17 (12) 2/10 (20) 
Popliteal 1/16 (6) 1/20 (5) 2/15 (13) 
Tibiai (Anterior and Posterior) 0/24 (0) 6/40 (15) 2/15 (13) 
Group III 
Superficial femoral 7/35 (20) 6/40 (15) 16/50 (32) 
Popliteal 2/16 (7) 2/40 (5) 4/41 (4) 
Tibiai (Anterior and Posterior) 4/62 (6) 22/80 (28) 8/88 (9) 
Totals 18/182 (10) 39/237 (16) 34/219 (16) 
*Groups 
Group I: Non-operated contralateral extremity in a patient with a femoral popliteal bypass 
Group II: Donor extremity in a patient with a femoral to femoral bypass; extremities contralateral to an iliac artery balloon angioplasty 
Group III: Extremities revascularized with a suprainguinal bypass or angioplasty 
Group IV: Extremities revascularized with a femoral popliteal bypass 
change thc result that having a femoropopliteal 
bypass is in itself a risk factor for greater progression 
of arterial occlusive disease (p = 0.009, odds ratio 
2.8). In patients examined more than 4 years after 
infrainguinal bypass (groups 1 and 4), progression 
was found in 31% of the arteries. Progression was 
found in 16% of the arteries in patients examined 
more than 4 years after a suprainguinal bypass 
(extremity groups 2 and 3) (p = 0.003) (Table II). 
Progression was particularly frequent among the 
initially nonoperated extremities of patients who had 
a femoral popliteal bypass. Forty percent of group 1 
extremities examined more than 4 years after baseline 
arteriography demonstrated progression of  femo- 
ropopliteal disease compared with 16% of group 2 
(p = 0.163) and 22% of group 3 extremities 
(p = 0.140). This was due to progression of  femo- 
ropopliteal disease in group 1 extremities because 
tibial artery progression occurred in only 9% of 
group 1 extremities versus 37% of Group 4 extremi- 
ties examined at 4 years (do = 0.025) (Table II). 
There were no significant differences in the 
prevalence of  superficial femoral artery or popliteal 
artery progression i revascularized versus nonrevas- 
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cularized extremities ofpatients undergoing suprain- 
guinal bypass. Similarly, except in examinations 
performed atmore than 4 years (37% versus 9%,p = 
0.001), there was no difference in tibial artery 
progression i operated and nonoperated xtremities 
of patients undergoing femoropopliteal bypass 
(Table II). 
DISCUSSION 
Despite the prevalence of symptomatic lower 
extremity atherosderosis, tittle is known with respect 
to its progression after lower extremity revascular- 
ization. To our knowledge, this study represents he 
first attempt to systematically gather anatomic data in 
a large number of patients documenting the preva- 
lence of segmental progression of lower extremity 
atherosclerosis after revascularization for chronic 
lower extremity ischemia. This study was possible 
because of the documented accuracy of lower extrem- 
ity arterial duplex scanning in assessing infrainguinal 
arteries from the groin to the ankle. 13 
This study demonstrates that progression of 
lower extremity atherosclerosis after revasculariza- 
tion occurs frequently. After a mean follow-up 
interval of 4.8 years, 53% of the i51 patients 
evaluated had progression of lower extremity athero- 
sclerosis on follow-up angiographic orduplex exami- 
nation. Not surprisingly, the prevalence ofdetectable 
disease progression increased significantly with in- 
creased length of follow-up. Only two patients 
exhibited spontaneous regression of superficial femo- 
ral artery stenosis from 50% to 99% to less than 50%. 
This reconfirms the observations of Brown et al.14 
that spontaneous regression of atherosclerotic arter- 
ies, although infrequent, can occur. 
The 53% prevalence ofdisease progression dem- 
onstrated by anatomic studies in this group of 
patients who required lower extremity revasculariza- 
tion is higher than that documented by previous 
studies that use clinical history or indirect vascular 
laboratory testing of patients with intermittent clau- 
dication. Schadt et al)s determined that, in 362 
patients with intermittent claudication and moni- 
tored for an average of 9 years, only 7% showed 
evidence of symptomatic worsening by clinical his- 
tory. Jonason and Ringqniest 16 found in 224 patients 
with claudication that 21% of patients progressed by 
segmental cuff pressures over a mean follow-up of 6 
years. The higher prevalence of progression i  our 
study reflects the fact that considerable anatomic 
disease progression can occur without a change in 
clinical status. 
These data, in contrast to previous tudies with 
clinical endpoints to determine progression, indicate 
future studies seeking to document the effects of 
atherosclerotic r sk factor modification and medical 
therapies on progression of lower extremity athero- 
sclerosis will probably require fewer patients to 
determine fficacy if anatomic rather than clinical 
endpoints are used. This study may serve as a basis for 
power calculation to determine the minimum num- 
ber of patients required for randomization to detect 
the efficacy of a particular treatment on lower 
extremity atherosclerotic disease progression at cer- 
tain time intervals. For example, if a drug under 
investigation is proposed to significantly decrease 
atherosclerotic progression by 10% over 4 years in 
patients with chronic lower extremity ischemia, 1700 
patients will be required for randomization if a 
prevalence of patient progression from our study of 
66% at greater than 4 years is used. In contrast, a
drug proposed to delay progression by 50% would 
require only 70 patients to be randomized if the same 
progression rate and time interval from our study are 
applied. 
With the possible xception of smoking, none of 
the risk factors for atherosclerosis examined in this 
study were associated with higher prevalence of 
progression. This may indicate that patients with 
advanced lower extremity ischemia have well- 
established atherosclerosis that will inevitably 
progress in their lower extremities. As is true of most 
studies of lower extremity ischemia, the prevalence of
risk factors was very high. For instance, only 16 of 
151 patients were nonsmokers. Walsh et al) 7 also 
found that, in 38 patients evaluated by angiography 
or duplex scanning for progression of superficial 
femoral artery atherosclerosis, progression was not 
influenced by sex, age, diabetes, hypertension, or 
cessation of smoking. 
There was no consistent difference in the preva- 
lence of progression of lower extremity atheroscle- 
rosis in revascularized versus nonrevascularized limbs 
of patients undergoing revascularization for iliac 
artery occlusive disease or in the tibial arteries of 
operated and nonoperated limbs of patients under- 
going femoral popliteal bypass. Overall, however, 
progression was more prevalent in the arteries of 
patients undergoing operation for infrainguinal 
rather than suprainguinal occlusive disease. This 
difference was primarily due to the high prevalence of
progression of femoropopliteal disease in the con- 
tralateral limbs of patients initially undergoing femo- 
ropopliteal bypass. It therefore appears that revascu- 
larization in itself does not alter the progression of 
lower extremity atherosclerosis but that overall pro- 
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gression may be related to whether the patient's 
disease is primarily suprainguinal or infrainguinal. 
Patients admitted requiring an infrainguinal arterial 
reconstruction are clearly older and in part because o f  
this may have more aggressive atherosclerosis and 
ultimately a poorer prognosis than younger patients 
admitted for suprainguinal revascularization. Cer- 
tainly w,e and others have documented low overall 
survival rates in patients requiring infrainguinal 
arterial reconstruction. 18,I9 Because most patients in 
this study were only examined at a single point after 
surgery, the differences noted between groups should 
be regarded as tentative. Prospective longitudinal 
studies will be required to document progression of  
atherosclerosis in patients with lower extremity 
arterial occlusive disease, as well as to establish 
conclusively any differences because of  disease pat- 
tern and the type of  revascularization. 
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DISCUSSION 
Dr. D. Eugene Strandness (Seattle, Wash.). This 
study by McLafferty and his colleagues at Oregon presents 
preliminary data on disease progression in lower limb 
atherosclerosis. As noted this study represents one glimpse 
in time at variable intervals after the disease was first 
detected. The methods used were arteriography atthe first 
visit followed by duplex scanning at later times. The 
categories used were less than 50%, greater than 50%, and 
occlusion for the femoropopliteal segment and patency to 
occlusion for the arteries below the knee. Progression was 
inferred by moving from one duplex category to a higher 
one for the femoropopliteal nd tibial artery segments. 
The rate of progression was greater in patients under- 
going infrainguinal bypass as compared to those with 
suprainguinal surgery-21% versus 14% (p < 0.004). As 
expected the likelihood of finding disease progression was 
higher with longer follow-up. Surprisingly they could find 
no differences in the rate of progression when the patients 
were stratified by risk factors such as diabetes. 
This study raises several interesting questions about 
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disease progression, how it should be detected, and its 
impact on both limb function and outcome with or without 
surgery. The areas of great interest are as follows: (1) The 
distribution of disease is different in patients with type 2 
diabetes and patients without diabetes. It is well known 
that suprainguinal disease is less frequent in patients with 
type 2 diabetes, the same in the femoropopopliteal area and 
higher in the tibial and peroneal arteries. We have shown 
that both the prevalence and progression rates for these two 
populations are different. In our studies, the patients were 
recruited for long-term follow-up and were not first seen in 
a vascular clinic. These are different populations as com- 
pared with this series. For example the prevalence in 
patients with type 2 diabetes was 22% compared with 3% 
in our control subjects. At 2 years 18% of the patients with 
type 2 diabetes had development ofnew disease, and 87% 
showed worsening by ankle/brachial indexes (ABI). (2) 
How can disease progression be documented? In our 
studies we used the ABI alone, which reflects global 
changes and does not assess the site or manner of disease 
progression. Obviously, it would be best to combine the 
pressure measurements with imaging. (3) Atherosclerosis 
progresses in two ways that are important but difficult to 
document unless one examines the arterial segment directly 
by some imaging technique as was used here. A plaque can 
progress by simply increasing the degree of narrowing or 
the involved arterial segment can thrombose leaving the 
artery totally occluded. It would be interesting to know 
which of these mechanisms were more common. Although 
there is little doubt that thrombosis is a very common 
terminal event, it is not yet clear if this is a process 
independent ofthe atherosclerosis it elf. (4) For the patient 
and the physician, the importance of disease progression 
relates to limb function-the extent to which walking 
ability is decreased and ultimately the likelihood of limb 
loss. Limb loss rates are extremely low with this disease 
even when untreated, so I doubt if this question can be 
answered without very large numbers of patients. (5) For 
us as surgeons disease progression can be an important 
cause of graft failure, but it is my impression from our own 
studies that it is a relatively infrequent cause of vein graft 
loss. This would appear to be borne out by the numerous 
ongoing studies of vein graft function and how long-term 
patency can be increased. 
Finally, from an epidemiologic standpoint, it will be 
important to assess the role of contributing risk factors on 
disease progression. This might permit us to assess which 
risk factors can be controlled and reduce the rate of 
progression. In our own studies we examined the impact of 
single risk factors and combinations to assess their impact 
on both the prevalence of disease and rate of progression. 
It became clear that risk factors appear to be additive. 
Finally, there are only two areas in the arterial 
circulation where these types of studies can be done by 
examining the arteries directly. These are of course the 
carotid and peripheral arteries. The coronary arteries have 
been the most widely studied, but here one is forced to look 
at either death or myocardial infarction as the outcome 
variables. 
Dr. Robert B. McLafferty. Your first question is an 
excellent one regarding the risk factors, and at first glance 
it may seem surprising that the risk factors didn't seem to 
vary with progression i  this study. The important point 
regarding this study is that the risk factors didn't involve 
our original question in terms of determining prevalence of 
progression. We did screen the patients and determine 
what the risk factors were in this particular group with 
severe atherosclerotic disease, but the study was very biased 
toward a group of patients having many atherosclerotic r sk 
factors. Those patients who did not have risk factors were 
few. Therefore we could not achieve statistical significance 
in the differences. This study does not contradict previous 
studies pecifically examining the questions of smoking or 
diabetes. 
With regard to your question of documenting progres- 
sion, this study hasn't been correlated yet to patients' 
symptoms or ABIs. I think that's a very important question 
that needs to be answered. 
In terms of addressing the question about whether 
occlusion leads to thrombosis or thrombosis occurs before 
critical stenosis, I don't believe our study regarding that 
question can be answered. It's a very interesting phenom- 
enom to study. Perhaps a well-controlled animal model 
could answer that specific question. 
With regard to vein graft failure caused by development 
of poor outflow, our study didn't show any differences in 
progression i arteries distal to revascularizations except at 
greater than 4 years for femoropopliteal bypasses. That may 
be one reason that outflow is not a major cause of graft flow 
failure. 
Dr. Calvin B. Ernst (Detroit, Mich.). Did you 
correlate progression of outflow disease with the type of 
bypass used? Can the prosthetic graft flow surface be 
implicated in activation of mitogenic factors to cause 
progression of outflow disease? It might be worth looking 
at the prosthesis or bypass used and correlate this with 
progression of outflow disease. 
Dr. McLafferty. Well, unfortunately, in this study all 
the patients with a femoropopliteal bypass had vein bypass, 
and we did not have any patients with polytetrafluoroeth- 
ylene (PTFE). With regard to the donor extremity of our 
inflow or suprainguinal revascularizations, all patients had 
femorofemoral bypasses that used PTFE. I think that your 
point regarding platelet activation and whether there's 
some sort of relationship between that and PTFE is a good 
one. I'm not sure how we could address or study that 
particular part of your question regarding the data in this 
study. 
